1.64 -0.02 (-1.18%)
BPAX
| Trade BPAX now with |
Stock Details
Last Trade:1.64 Change:-0.02 (-1.18%) Prev Close:1.66 Open: 1.70 Days Range:1.64 – 1.70 52 Week Range: 1.29 - 2.50 Volume:1409203 P/E: N/AEPS:-1.44
View AllRecent Alerts 12/31/10
Recent Alert on 12/31/10 at 2:15pm
BioSante Pharma (BPAX) Closes $18M Direct Offering
BioSante Pharma (BPAX) Closes $18M Direct Offering
BioSante Pharmaceuticals, Inc. (Nasdaq: BPAX) announced that they have closed a previously announced sale of an aggregate of $18 million of securities in a registered direct offering. BioSante received net proceeds of approximately $16.9 million... Read More
Recent Alert on 12/28/10 at 1:25pm
Unusual 11 Mid-Day Movers 12/28: CAVO, REE, CHGS, SHZ, GRO, VVTV Higher; XOMA, DARA, BPAX, RPC, FFHL Lower
Unusual 11 Mid-Day Movers 12/28: CAVO, REE, CHGS, SHZ, GRO, VVTV Higher; XOMA, DARA, BPAX, RPC, FFHL Lower
Recent Alert on 12/28/10 at 10:13am
Morning Movers 12/28: CAVO, SNTS, SHZ, MCP Higher; FFHL, BPAX, XOMA, CPD, DARA Lower
Morning Movers 12/28: CAVO, SNTS, SHZ, MCP Higher; FFHL, BPAX, XOMA, CPD, DARA Lower
View AllRecent Press Releases
Press Release on 12/31/10 at 2:13pm
BioSante Pharmaceuticals Closes $18 Million Registered Direct Offering to Fund LibiGel® for Female Sexual Dysfunction
BioSante Pharmaceuticals Closes $18 Million Registered Direct Offering to Fund LibiGel® for Female Sexual Dysfunction
Press Release on 12/30/10 at 12:51pm
PennyKings.com Morning Report: Neurokine Pharmaceuticals, Repros Therapeutics Inc., Pfizer, Xoma Ltd., Biosante Pharmaceuticals, Valence Technologies, and Arena Pharmaceuticals
PennyKings.com Morning Report: Neurokine Pharmaceuticals, Repros Therapeutics Inc., Pfizer, Xoma Ltd., Biosante Pharmaceuticals, Valence Technologies, and Arena Pharmaceuticals
Press Release on 12/28/10 at 8:30am
Rodman & Renshaw Acts as Exclusive Placement Agent to BioSante Pharmaceuticals, Inc. on $18.0 Million Registered Direct Offering
Rodman & Renshaw Acts as Exclusive Placement Agent to BioSante Pharmaceuticals, Inc. on $18.0 Million Registered Direct Offering
Press Release on 12/27/10 at 6:33pm
BioSante Pharmaceuticals to Raise $18 Million in Registered Direct Offering
BioSante Pharmaceuticals to Raise $18 Million in Registered Direct Offering
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 12/28/10 at 3:50am
BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011
BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011
Blog Posts on 12/27/10 at 5:24am
Is BioSante Pharmaceuticals Next in Line to Receive Institutional Praise?
Is BioSante Pharmaceuticals Next in Line to Receive Institutional Praise?